ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (REGN34)

60.64
0.00
(0.00%)
Closed March 28 4:55PM

Regeneron Pharmaceuticals Inc Financial Summary

The current REGN34 market cap is 6.55B. The company's latest EPS is USD 40.8302 and P/E is 15.57.

Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 8.78B16.12B12.26B13.12B14.2B
Operating Income 3.58B8.95B4.74B4.05B3.99B
Net Income 3.51B8.08B4.34B3.95B4.41B
Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 17.16B25.43B29.21B33.08B37.76B
Total Liabilities 6.14B6.67B6.55B7.11B8.41B
Total Equity 11.03B18.77B22.66B25.97B29.35B
Year End December 30 2024 20202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.62B7.08B5.01B4.59B4.42B
Investing -70.6M-5.38B-3.78B-3.19B-2.47B
Financing -1.97B-1.01B-1.01B-1.79B-2.2B
Market Cap 6.55B
Price to Earnings Ratio 15.57
Price to Sales Ratio 4.84
Price to Cash Ratio 27.62
Price to Book Ratio 2.34
Dividend Yield 0.10%

Share Statistics

Shares Outstanding 108.07M
Average Volume (1 week) 469
Average Volume (1 Month) 2.49k
52 Week Change -24.04%
52 Week High 111.72
52 Week Low 60.11
Spread (Intraday) 13.03 (17.84%)

Company Info

Company Name Regeneron Pharmaceuticals Inc
Address 28 liberty street
new york, new york 10005
Website https://www.regeneron.com
Industry health care diversified (H)